Man Group plc Invests $501,000 in Phibro Animal Health Co. (NASDAQ:PAHC)

Man Group plc bought a new position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 23,836 shares of the company's stock, valued at approximately $501,000. Man Group plc owned approximately 0.06% of Phibro Animal Health as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Lazard Asset Management LLC grew its position in Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after acquiring an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC acquired a new stake in Phibro Animal Health in the fourth quarter valued at approximately $69,000. Quantbot Technologies LP grew its position in Phibro Animal Health by 65.1% in the fourth quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock valued at $107,000 after acquiring an additional 2,018 shares in the last quarter. Meeder Asset Management Inc. purchased a new position in shares of Phibro Animal Health during the 4th quarter valued at approximately $113,000. Finally, New York State Teachers Retirement System boosted its stake in shares of Phibro Animal Health by 16.7% during the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock valued at $114,000 after buying an additional 775 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on PAHC shares. Morgan Stanley increased their target price on Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research note on Thursday, May 8th. Barclays increased their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Finally, Wall Street Zen upgraded Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $20.00.

Phibro Animal Health Stock Performance

PAHC traded up $0.16 during trading hours on Thursday, hitting $24.66. 287,569 shares of the stock were exchanged, compared to its average volume of 200,318. The stock has a 50-day simple moving average of $20.41 and a 200-day simple moving average of $21.90. Phibro Animal Health Co. has a 12 month low of $16.16 and a 12 month high of $26.55. The stock has a market cap of $999.57 million, a price-to-earnings ratio of 51.38, a price-to-earnings-growth ratio of 0.45 and a beta of 0.62. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The firm had revenue of $347.80 million for the quarter, compared to analysts' expectations of $352.41 million. Analysts anticipate that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.95%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.